PAREXEL International Corp (NASDAQ:PRXL)
CAPS Rating:
The Company provides a range of expertise in clinical research, medical communications services, consulting, and informatics and advanced technology products and services to the worldwide pharmaceutical, biotechnology, and medical device industries.
RSS Headlines
Fool UK
Recs
Considerable backlog exists for the services of this clinical research and marketing company whose stock has taken an unjustified hit of late.